TY - JOUR AU - Banales, J. M. AU - Cardinale, V. AU - Carpino, G. AU - Marzioni, M. AU - Andersen, J. B. AU - Invernizzi, P. PY - 2016 DA - 2016// TI - Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European network for the study of cholangiocarcinoma (ENS-CCA) JO - Nat Rev Gastroenterol Hepatol VL - 13 UR - https://doi.org/10.1038/nrgastro.2016.51 DO - 10.1038/nrgastro.2016.51 ID - Banales2016 ER - TY - JOUR AU - Ruzzenente, A. AU - Fassan, M. AU - Conci, S. AU - Simbolo, M. AU - Lawlor, R. T. AU - Pedrazzani, C. PY - 2016 DA - 2016// TI - Cholangiocarcinoma heterogeneity revealed by multigene mutational profiling: clinical and prognostic relevance in surgically resected patients JO - Ann Surg Oncol VL - 23 UR - https://doi.org/10.1245/s10434-015-5046-6 DO - 10.1245/s10434-015-5046-6 ID - Ruzzenente2016 ER - TY - JOUR AU - Sayiner, M. AU - Koenig, A. AU - Henry, L. AU - Younossi, Z. M. PY - 2016 DA - 2016// TI - Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world JO - Clin Liver Dis VL - 20 UR - https://doi.org/10.1016/j.cld.2015.10.001 DO - 10.1016/j.cld.2015.10.001 ID - Sayiner2016 ER - TY - JOUR AU - Seto, W. K. AU - Yuen, M. F. PY - 2017 DA - 2017// TI - Nonalcoholic fatty liver disease in Asia: emerging perspectives JO - J Gastroenterol VL - 52 UR - https://doi.org/10.1007/s00535-016-1264-3 DO - 10.1007/s00535-016-1264-3 ID - Seto2017 ER - TY - JOUR AU - Vernon, G. AU - Baranova, A. AU - Younossi, Z. M. PY - 2011 DA - 2011// TI - Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults JO - Aliment Pharmacol Ther VL - 34 UR - https://doi.org/10.1111/j.1365-2036.2011.04724.x DO - 10.1111/j.1365-2036.2011.04724.x ID - Vernon2011 ER - TY - JOUR AU - Younossi, Z. M. AU - Otgonsuren, M. AU - Henry, L. AU - Venkatesan, C. AU - Mishra, A. AU - Erario, M. PY - 2015 DA - 2015// TI - Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009 JO - Hepatology (Baltimore, Md) VL - 62 UR - https://doi.org/10.1002/hep.28123 DO - 10.1002/hep.28123 ID - Younossi2015 ER - TY - JOUR AU - Sanna, C. AU - Rosso, C. AU - Marietti, M. AU - Bugianesi, E. PY - 2016 DA - 2016// TI - Non-alcoholic fatty liver disease and extra-hepatic cancers JO - Int J Mol Sci VL - 17 UR - https://doi.org/10.3390/ijms17050717 DO - 10.3390/ijms17050717 ID - Sanna2016 ER - TY - JOUR AU - Eng, G. AU - Zukerberg, L. AU - Deshpande, V. PY - 2016 DA - 2016// TI - The incidence of steatosis and steatohepatitis in intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma [Abstract] JO - Lab Investig VL - 96 ID - Eng2016 ER - TY - JOUR AU - Kinoshita, M. AU - Kubo, S. AU - Tanaka, S. AU - Takemura, S. AU - Nishioka, T. AU - Hamano, G. PY - 2016 DA - 2016// TI - The association between non-alcoholic steatohepatitis and intrahepatic cholangiocarcinoma: a hospital based case-control study JO - J Surg Oncol VL - 113 UR - https://doi.org/10.1002/jso.24223 DO - 10.1002/jso.24223 ID - Kinoshita2016 ER - TY - JOUR AU - Welzel, T. M. AU - Graubard, B. I. AU - El-Serag, H. B. AU - Shaib, Y. H. AU - Hsing, A. W. AU - Davila, J. A. PY - 2007 DA - 2007// TI - Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study JO - Clin Gastroenterol Hepatol VL - 5 UR - https://doi.org/10.1016/j.cgh.2007.05.020 DO - 10.1016/j.cgh.2007.05.020 ID - Welzel2007 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. AU - Altman, D. G. PY - 2009 DA - 2009// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - PLoS Med VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000097 DO - 10.1371/journal.pmed.1000097 ID - Moher2009 ER - TY - STD TI - Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M et al.. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. 2011. [website]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Available from: URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 1 Nov 2015. UR - http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp ID - ref12 ER - TY - JOUR AU - Liu, Y. AU - He, Y. AU - Li, T. AU - Xie, L. AU - Wang, J. AU - Qin, X. PY - 2014 DA - 2014// TI - Risk of primary liver cancer associated with gallstones and cholecystectomy: a meta-analysis JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0109733 DO - 10.1371/journal.pone.0109733 ID - Liu2014 ER - TY - STD TI - Chaiteerakij R, Yang JD, Harmsen WS, Slettedahl SW, Mettler TA, Fredericksen ZS, et al. Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk. Hepatology. 2013;57:648–55. ID - ref14 ER - TY - JOUR AU - Huang, Y. J. AU - ATH, W. AU - Chiou, H. Y. AU - Chuang, M. T. AU - Meng, T. C. AU - Chien, L. N. PY - 2017 DA - 2017// TI - Interactive role of diabetes mellitus and female sex in the risk of cholangiocarcinoma: a population-based nested case-control study JO - Oncotarget VL - 8 ID - Huang2017 ER - TY - STD TI - Choi J, Ghoz HM, Peeraphatdit T, Baichoo E, Addissie BD, Harmsen WS, et al. Aspirin use and the risk of cholangiocarcinoma. Hepatology. 2016;64:785–96. ID - ref16 ER - TY - STD TI - Chang JS, Tsai CR, Chen LT. Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control study. PloS one. 2013;8:e69981. ID - ref17 ER - TY - JOUR AU - Lee, B. S. AU - Cha, B. H. AU - Park, E. C. AU - Roh, J. PY - 2015 DA - 2015// TI - Risk factors for perihilar cholangiocarcinoma: a hospital-based case-control study JO - Liver Int VL - 35 UR - https://doi.org/10.1111/liv.12618 DO - 10.1111/liv.12618 ID - Lee2015 ER - TY - JOUR AU - Stepien, M. AU - Fedirko, V. AU - Duarte-Salles, T. AU - Ferrari, P. AU - Freisling, H. AU - Trepo, E. PY - 2016 DA - 2016// TI - Prospective association of liver function biomarkers with development of hepatobiliary cancers JO - Cancer Epidemiol VL - 40 UR - https://doi.org/10.1016/j.canep.2016.01.002 DO - 10.1016/j.canep.2016.01.002 ID - Stepien2016 ER - TY - JOUR AU - Zhou, H. B. AU - QR, X. AU - Wang, H. AU - Zhou, D. X. AU - Wang, H. AU - Wang, Q. PY - 2009 DA - 2009// TI - Risk factors of intrahepatic cholangiocarcinoma: a case-control study JO - Zhonghua Gan Zang Bing Za Zhi VL - 17 ID - Zhou2009 ER - TY - JOUR AU - Doycheva, I. AU - Cox, K. AU - Haseeb, A. AU - Adler, D. G. PY - 2014 DA - 2014// TI - Prevalence and relevance of nonalcoholic fatty liver disease in patients with primary sclerosing cholangitis JO - Dig Dis Sci VL - 59 UR - https://doi.org/10.1007/s10620-014-3051-4 DO - 10.1007/s10620-014-3051-4 ID - Doycheva2014 ER - TY - JOUR AU - Raggi, C. AU - Invernizzi, P. AU - Andersen, J. B. PY - 2015 DA - 2015// TI - Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts JO - J Hepatol VL - 62 UR - https://doi.org/10.1016/j.jhep.2014.09.007 DO - 10.1016/j.jhep.2014.09.007 ID - Raggi2015 ER - TY - JOUR AU - Adams, L. A. AU - Lymp, J. F. AU - St. Sauver, J. AU - Sanderson, S. O. AU - Lindor, K. D. AU - Feldstein, A. PY - 2010 DA - 2010// TI - The natural history of nonalcoholic fatty liver disease: a population-based cohort study JO - Gastroenterology VL - 129 UR - https://doi.org/10.1053/j.gastro.2005.04.014 DO - 10.1053/j.gastro.2005.04.014 ID - Adams2010 ER - TY - JOUR AU - Carter-Kent, C. AU - Zein, N. N. AU - Feldstein, A. E. PY - 2008 DA - 2008// TI - Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment JO - Am J Gastroenterol VL - 103 UR - https://doi.org/10.1111/j.1572-0241.2007.01709.x DO - 10.1111/j.1572-0241.2007.01709.x ID - Carter-Kent2008 ER - TY - JOUR AU - Okazaki, I. AU - Noro, T. AU - Tsutsui, N. AU - Yamanouchi, E. AU - Kuroda, H. AU - Nakano, M. PY - 2014 DA - 2014// TI - Fibrogenesis and carcinogenesis in nonalcoholic steatohepatitis (NASH): involvement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs) JO - Cancers VL - 6 UR - https://doi.org/10.3390/cancers6031220 DO - 10.3390/cancers6031220 ID - Okazaki2014 ER - TY - JOUR AU - Wehbe, H. AU - Henson, R. AU - Meng, F. AU - Mize-Berge, J. AU - Patel, T. PY - 2006 DA - 2006// TI - Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-2130 DO - 10.1158/0008-5472.CAN-06-2130 ID - Wehbe2006 ER - TY - JOUR AU - Jaiswal, M. AU - LaRusso, N. F. AU - Shapiro, R. A. AU - Billiar, T. R. AU - Gores, G. J. PY - 2001 DA - 2001// TI - Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes JO - Gastroenterology VL - 120 UR - https://doi.org/10.1053/gast.2001.20875 DO - 10.1053/gast.2001.20875 ID - Jaiswal2001 ER - TY - JOUR AU - Ishimura, N. AU - Bronk, S. F. AU - Gores, G. J. PY - 2004 DA - 2004// TI - Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth JO - Am J Physiol Gastrointest Liver Physiol VL - 287 UR - https://doi.org/10.1152/ajpgi.00539.2003 DO - 10.1152/ajpgi.00539.2003 ID - Ishimura2004 ER - TY - JOUR AU - Guest, R. V. AU - Boulter, L. AU - Kendall, T. J. AU - Minnis-Lyons, S. E. AU - Walker, R. AU - Wigmore, S. J. PY - 2014 DA - 2014// TI - Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-13-1911 DO - 10.1158/0008-5472.CAN-13-1911 ID - Guest2014 ER -